BLFS
Price
$22.67
Change
-$0.17 (-0.74%)
Updated
Feb 4 closing price
Capitalization
1.09B
35 days until earnings call
Intraday BUY SELL Signals
RMD
Price
$263.03
Change
+$11.62 (+4.62%)
Updated
Feb 4 closing price
Capitalization
38.32B
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLFS vs RMD

Header iconBLFS vs RMD Comparison
Open Charts BLFS vs RMDBanner chart's image
BioLife Solutions
Price$22.67
Change-$0.17 (-0.74%)
Volume$687.82K
Capitalization1.09B
ResMed
Price$263.03
Change+$11.62 (+4.62%)
Volume$1.73M
Capitalization38.32B
BLFS vs RMD Comparison Chart in %
BLFS
Daily Signal:
Gain/Loss:
RMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BLFS vs. RMD commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and RMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (BLFS: $22.67 vs. RMD: $263.03)
Brand notoriety: BLFS and RMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BLFS: 204% vs. RMD: 172%
Market capitalization -- BLFS: $1.09B vs. RMD: $38.32B
BLFS [@Pharmaceuticals: Other] is valued at $1.09B. RMD’s [@Pharmaceuticals: Other] market capitalization is $38.32B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileRMD’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • RMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RMD is a better buy in the long-term than BLFS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 4 TA indicator(s) are bullish while RMD’s TA Score has 6 bullish TA indicator(s).

  • BLFS’s TA Score: 4 bullish, 5 bearish.
  • RMD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RMD is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -1.18% price change this week, while RMD (@Pharmaceuticals: Other) price change was +2.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -1.97%, and the average quarterly price growth was +23.00%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 12, 2026.

RMD is expected to report earnings on Apr 23, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($38.3B) has a higher market cap than BLFS($1.09B). RMD YTD gains are higher at: 9.200 vs. BLFS (-6.245). RMD has higher annual earnings (EBITDA): 2B vs. BLFS (-14.25M). RMD has more cash in the bank: 1.38B vs. BLFS (79M). BLFS has less debt than RMD: BLFS (20.7M) vs RMD (846M). RMD has higher revenues than BLFS: RMD (5.26B) vs BLFS (100M).
BLFSRMDBLFS / RMD
Capitalization1.09B38.3B3%
EBITDA-14.25M2B-1%
Gain YTD-6.2459.200-68%
P/E RatioN/A26.02-
Revenue100M5.26B2%
Total Cash79M1.38B6%
Total Debt20.7M846M2%
FUNDAMENTALS RATINGS
BLFS vs RMD: Fundamental Ratings
BLFS
RMD
OUTLOOK RATING
1..100
614
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
10076
SMR RATING
1..100
9036
PRICE GROWTH RATING
1..100
6257
P/E GROWTH RATING
1..100
1562
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (37) in the Medical Specialties industry is somewhat better than the same rating for BLFS (99). This means that RMD’s stock grew somewhat faster than BLFS’s over the last 12 months.

RMD's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as BLFS (100). This means that RMD’s stock grew similarly to BLFS’s over the last 12 months.

RMD's SMR Rating (36) in the Medical Specialties industry is somewhat better than the same rating for BLFS (90). This means that RMD’s stock grew somewhat faster than BLFS’s over the last 12 months.

RMD's Price Growth Rating (57) in the Medical Specialties industry is in the same range as BLFS (62). This means that RMD’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (15) in the Medical Specialties industry is somewhat better than the same rating for RMD (62). This means that BLFS’s stock grew somewhat faster than RMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSRMD
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
54%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 9 days ago
62%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 3 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signal:
Gain/Loss:
RMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSSCX19.380.24
+1.25%
Columbia Small Cap Value Discv C
PISOX15.220.16
+1.06%
Columbia Pyrford International Stk Ins 2
RLSMX12.480.06
+0.48%
Lazard US Small Cap Equity Select R6
FFIDX113.15N/A
N/A
Fidelity
IGLGX20.56-0.50
-2.37%
Columbia Select Global Equity A

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-0.74%
RGEN - BLFS
56%
Loosely correlated
-2.74%
SMTI - BLFS
52%
Loosely correlated
+0.92%
RVTY - BLFS
51%
Loosely correlated
+2.67%
A - BLFS
50%
Loosely correlated
+0.64%
AZTA - BLFS
47%
Loosely correlated
-22.81%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with BLFS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+4.62%
BLFS - RMD
44%
Loosely correlated
-0.74%
SMTI - RMD
43%
Loosely correlated
+0.92%
SOLV - RMD
40%
Loosely correlated
+0.98%
RVTY - RMD
40%
Loosely correlated
+2.67%
SYK - RMD
39%
Loosely correlated
-0.04%
More